Core Viewpoint - The major shareholder of Juhe Shun (605166.SH) plans to reduce its holdings due to personal funding needs, which may impact the company's stock performance [1] Summary by Category Shareholder Actions - Hainan Yongchang intends to reduce its stake through two methods: a maximum of 3.1472 million shares via competitive bidding, accounting for no more than 1% of the total share capital, and up to 6.2945 million shares through block trading, representing no more than 2% of the total share capital [1] Timeline - The reduction period is set to begin 15 trading days after the announcement, lasting from September 25, 2025, to December 24, 2025 [1]

格隆汇9月3日｜聚合顺公告，截至本公告日，持股5%以上股东海南永昌新材料有限公司持有公司 3486.85万股，占11.08%；因自身资金需求，计划于2025年9月25日至2025年12月24日，通过集中竞价减 持不超过314.72万股、大宗交易减持不超过629.45万股，合计不超过944.17万股，减持比例不超过3%， 所减股份均来源于IPO前取得。 ...

Company Overview - Juhe Shun New Materials Co., Ltd. is located in Hangzhou, Zhejiang Province, established on November 1, 2013, and listed on June 18, 2020. The company specializes in the research, production, and sales of nylon new materials [1]. Business Composition - The main business revenue composition is as follows: fiber-grade slices account for 65.57%, engineering plastic-grade slices 30.63%, film-grade slices 3.33%, other slices 0.43%, and materials 0.04% [1]. Stock Performance - On September 2, Juhe Shun's stock fell by 5.08%, closing at 12.51 yuan per share, with a trading volume of 144 million yuan and a turnover rate of 3.58%. The total market capitalization is 3.937 billion yuan [1]. Major Shareholders - Among the top ten circulating shareholders, one fund from the Fortune Fund, specifically Fortune Optimized Enhanced Bond C (100037), entered the top ten in the second quarter, holding 2.1614 million shares, which is 0.69% of the circulating shares. The estimated floating loss today is approximately 1.4481 million yuan [2]. Fund Performance - Fortune Optimized Enhanced Bond C (100037) was established on June 10, 2009, with a latest scale of 553 million yuan. Year-to-date returns are 19.95%, ranking 54 out of 6228 in its category; the one-year return is 43.71%, ranking 21 out of 5859; and since inception, the return is 142.82% [2]. Fund Management - The fund manager of Fortune Optimized Enhanced Bond C is Liu Xingwang, who has a cumulative tenure of 14 years and 210 days. The total asset scale under management is 15.304 billion yuan, with the best fund return during his tenure being 54.42% and the worst being 0.3% [3].

Company Overview - 聚合顺新材料股份有限公司 is located in Hangzhou, Zhejiang Province, established on November 1, 2013, and listed on June 18, 2020 [1] - The company specializes in the research, production, and sales of nylon new materials, with revenue composition as follows: 65.57% from fiber-grade slices, 30.63% from engineering plastic-grade slices, 3.33% from film-grade slices, 0.43% from other slices, and 0.04% from materials [1] Stock Performance - As of September 1, the stock price increased by 2.17% to 13.18 CNY per share, with a trading volume of 1.87 billion CNY and a turnover rate of 4.56%, resulting in a total market capitalization of 4.148 billion CNY [1] - Year-to-date, the stock price has risen by 11.35%, with a 5-day increase of 5.19%, a 20-day increase of 17.05%, and a 60-day increase of 6.32% [1] Financial Performance - For the period from January to June 2025, the company reported a revenue of 3.030 billion CNY, a year-on-year decrease of 13.87%, and a net profit attributable to shareholders of 111 million CNY, down 27.60% year-on-year [2] - Cumulative cash dividends since the A-share listing amount to 295 million CNY, with 198 million CNY distributed over the past three years [2] Shareholder Information - As of August 20, the number of shareholders increased to 19,500, with an average of 16,148 circulating shares per person, a decrease of 0.32% [2] - Notable changes in institutional holdings include交银趋势混合A (519702) as the sixth largest shareholder with 2.2113 million shares, down by 7.6843 million shares, and富国优化增强债券C (100037) entering as the eighth largest shareholder with 2.1614 million shares [2]

Financial Performance - In the first half of 2025, the company achieved operating revenue of 3.03 billion yuan, a year-on-year decrease of 13.87% [1] - The net profit attributable to the parent company was 111 million yuan, down 27.60% year-on-year [1] - In Q2 2025, operating revenue was 1.47 billion yuan, a year-on-year decline of 21.93% and a quarter-on-quarter decline of 6.11% [1] - The net profit attributable to the parent company in Q2 was 30 million yuan, a significant year-on-year decrease of 63.87% and a quarter-on-quarter decrease of 63.07% [1] Market Conditions - The decline in performance in Q2 2025 was primarily due to the downturn in the PA6 market [2] - The average price of caprolactam in Q2 2025 was 9,180 yuan/ton, down 12.7% quarter-on-quarter [2] - The average price of PA6 conventional spinning was 10,087 yuan/ton, down 12.2% quarter-on-quarter [2] - The price differences for PA6 products also saw significant declines, indicating pressure from global trade tensions and domestic demand [3] Production Capacity and Future Outlook - The company has production bases in Hangzhou, Changde, Tengzhou, and Zibo, with several projects expected to come online in the next two years [3] - The company anticipates a significant increase in PA6 demand driven by trends in outdoor economy and lightweight automotive applications [4] - The PA6 production capacity is projected to reach 7.87 million tons in 2024, a year-on-year increase of 24% [4] - The company is also focusing on the PA66 market, which is expected to benefit from engineering plastic demand growth [4] Profit Forecast - The company forecasts net profits attributable to the parent company of 280 million yuan, 380 million yuan, and 530 million yuan for 2025, 2026, and 2027 respectively [5] - Corresponding PE ratios based on the closing price on August 29, 2025, are projected to be 14.4X, 10.7X, and 7.7X [5]

Core Viewpoint - The company, 聚合顺, is actively addressing challenges such as intensified industry competition, weak downstream demand, and external trade disruptions while focusing on strengthening its core business and expanding its international market presence [1]. Company Overview - 聚合顺 is a national-level high-tech enterprise specializing in the research, production, and sales of nylon 6 chips, with a focus on maintaining a competitive edge through technological and management advantages [2]. - The company has established multiple production bases across Zhejiang, Shandong, and Hunan, and has developed a systematic production planning, supply chain, and management system over its ten years of operation [2]. Business Performance - For the first half of 2025, the company produced 299,268.46 tons of nylon chips, a year-on-year increase of 13.21%, and sold 293,195.21 tons, up 11.46% [1]. - The nylon 6 chip business accounts for over 95% of the company's main revenue, with fiber-grade chips contributing 65.60% and engineering plastic-grade chips 30.64% [1]. - The company's export revenue grew by over 65% year-on-year, with a significant international market presence in countries like India, South Korea, and Brazil [1]. Industry Context - The nylon chip industry is experiencing rapid capacity expansion, with an expected capacity of 8.5 million tons by the end of 2025, reflecting a 10% year-on-year increase [3]. - The industry faces oversupply pressures, with production expected to reach approximately 7 million tons against a consumption of about 6.4 million tons [3]. - The upstream caprolactam (CPL) capacity is projected to reach 7.4 million tons in 2025, with a year-on-year growth of nearly 7%, leading to a supply-demand imbalance and declining prices [3]. Strategic Initiatives - The company is advancing into high-end nylon chips, with plans to optimize its production projects to include various new nylon materials, enhancing product diversity and value [4]. - The company is also collaborating with China Tianchen to share interests in the PA66 market, with plans for an 80,000-ton PA66 project in Zibo, aiming for long-term growth [4]. - The company has a strong market position in differentiated products and has accumulated extensive customer resources, which are expected to enhance its competitiveness despite current industry pressures [5].

Summary of Conference Call Notes Company and Industry Overview - The company operates in the nylon chip industry, specifically focusing on the production of nylon 6 and related products. The industry is currently facing challenges due to fluctuating prices and demand dynamics. Key Points and Arguments 1. **Financial Performance**: In Q2 2025, the company reported a revenue decline of 22% year-on-year and a significant drop in net profit by 61.33%, marking the most challenging period in the last five years due to downstream demand and caprolactam price volatility [2][4][3]. 2. **Product Structure Adjustment**: The company is responding to market changes by adjusting its product structure, launching new product lines such as copolymer nylon 6/66 and high-temperature nylon 67, with plans to introduce these products to the market in Q4 2025 [2][14][15]. 3. **Overseas Market Growth**: The company's overseas business has seen significant growth, accounting for 11% of total sales, with India (48%), Brazil (21%), and South Korea (11%) being the primary markets [2][8]. 4. **Market Share and Competitive Advantage**: China holds over 80% of the global nylon chip market share, with expectations for further growth in overseas markets due to the exit of strategic capacities from competitors [2][9]. 5. **Production and Inventory Management**: The company reported a slight increase in nylon chip production in Q2, but a 26% decline in prices due to a nearly 30% fluctuation in caprolactam prices, leading to pressure on processing fees [2][10]. Inventory turnover is slow, with current average operating rates around 85% [5][11]. 6. **Domestic Market Dynamics**: The domestic PA6 consumption growth is estimated at 7%-10%, lower than public data suggesting 15%-20% growth, indicating a competitive and challenging market environment [5][18]. 7. **Impact of Raw Material Prices**: The decline in raw material prices has affected the company's profitability, with a noted decrease in processing fees and competitive pressures from peers selling at cost [13][17]. 8. **Future Strategies**: The company plans to enhance its competitive edge through differentiated high-end product lines and is exploring opportunities for industry chain iteration [35]. Additional Important Information 1. **Production Capacity Updates**: The company has various production bases, with significant capacity expansions planned, including a new 9.2 million-ton production line in Hunan [6][12]. 2. **Market Trends**: The textile industry is expected to see new capacity additions, but these may be delayed due to market conditions [5][18]. 3. **Trade War Effects**: The ongoing trade war has impacted the company's export capabilities, particularly to the U.S., but there are signs of recovery in the domestic market as trade tensions ease [30]. 4. **Technological Developments**: The company is exploring advancements in production technology, including the Gilkin process for caprolactam production, which could enhance its product offerings [20]. This summary encapsulates the critical insights from the conference call, highlighting the company's current challenges, strategic adjustments, and market positioning within the nylon chip industry.

Core Viewpoint - The financial report of Juhe Shun (605166) for the first half of 2025 shows a significant decline in both revenue and net profit, indicating potential challenges in the company's operational performance and market conditions [1]. Financial Performance - Total revenue for the first half of 2025 was 3.03 billion yuan, a decrease of 13.87% compared to the same period in 2024 [1]. - Net profit attributable to shareholders was 111 million yuan, down 27.6% year-on-year [1]. - In Q2 2025, total revenue was 1.467 billion yuan, reflecting a year-on-year decline of 21.93% [1]. - Q2 net profit attributable to shareholders was approximately 29.83 million yuan, a decrease of 63.87% compared to the previous year [1]. - Gross margin was 7.4%, down 9.98% year-on-year, while net margin was 4.09%, down 21.42% [1]. - Total expenses (selling, administrative, and financial) amounted to 2.2447 million yuan, representing an increase of 147.28% year-on-year [1]. Key Financial Ratios - Earnings per share (EPS) decreased to 0.35 yuan, down 27.08% year-on-year [1]. - The company's return on invested capital (ROIC) was 12.11% last year, indicating strong capital returns [3]. - The average operating cash flow per share was 0.36 yuan, an increase of 95.12% year-on-year [1]. Changes in Financial Items - Prepayments decreased by 36.82% due to reduced payments to suppliers [4]. - Deferred tax assets increased by 57.97% due to an increase in deductible temporary differences [4]. - Accounts payable decreased by 66.2% as the balance of income tax payable was lower than the previous year [4]. - Revenue decline was attributed to a decrease in product prices [4]. - Operating costs also fell by 13.1% due to lower raw material prices [4]. Cash Flow and Debt - The company’s cash assets are considered healthy, with cash and cash equivalents covering 99.09% of current liabilities [6]. - The net cash flow from operating activities increased by 94.6% due to reduced cash payments related to operations [4]. - The net cash flow from investing activities decreased by 66.24% due to increased project investments [4]. - The net cash flow from financing activities dropped by 131.81% as new borrowings by subsidiaries significantly decreased [4]. Market Position and Investment - The largest fund holding Juhe Shun shares is Guotai Junan Jun De Cheng Mixed Fund, with a scale of 120 million yuan [7]. - The fund's latest net value was 0.8091 as of August 27, showing a decline of 1.35% from the previous trading day, but an increase of 31.03% over the past year [7]. - The company’s business model relies heavily on capital expenditures, necessitating careful evaluation of the profitability of these investments [8].

Core Viewpoint - The company reported a decline in revenue and net profit for the first half of 2025, primarily due to fluctuations in raw material prices and weak downstream demand [1][2]. Financial Performance - In H1 2025, the company achieved revenue of 3.03 billion yuan, a year-on-year decrease of 13.87% [1] - The net profit attributable to shareholders was 111 million yuan, down 27.60% year-on-year [1] - The net profit after deducting non-recurring items was 109 million yuan, a decrease of 26.01% year-on-year [1] - In Q2 2025, revenue was 1.47 billion yuan, a year-on-year decline of 21.93% and a quarter-on-quarter decline of 6.11% [1] - The net profit attributable to shareholders in Q2 was 30 million yuan, down 63.87% year-on-year and 63.07% quarter-on-quarter [1] - The net profit after deducting non-recurring items in Q2 was 32 million yuan, a decrease of 61.33% year-on-year and 58.41% quarter-on-quarter [1] Industry Dynamics - The fluctuation in raw material prices, particularly the increase in pure benzene prices, led to a rise in caprolactam prices, which subsequently weakened procurement willingness in the downstream market [2] - In Q2 2025, the average price of caprolactam was 9,193 yuan/ton, a decrease of 12.65% compared to Q1 [2] - The PA6 chip average price in Q2 2025 was 10,270 yuan/ton, also down 12.65% from Q1 [2] - The nylon chip industry is expected to reach a production capacity of 8.5 million tons and a production volume of 7 million tons by the end of 2025, with demand at 6.4 million tons [2] - The company has a competitive edge in high-end nylon chip segments and has adjusted its production projects to align with market conditions [2] Future Outlook - The company is expected to enhance its competitiveness with the completion of new production bases and capacities [2] - The company has a long-term positive outlook despite current industry pressures, supported by its experience in nylon 6 polymerization and the introduction of nylon 66 products [3] - Projected net profits for 2025, 2026, and 2027 are estimated at 350 million, 456 million, and 553 million yuan, respectively, with corresponding PE ratios of 11, 9, and 7 [3]

Investment Rating - The report maintains a "Recommended" rating for the company [3][5]. Core Views - The company's revenue for H1 2025 was 3.03 billion yuan, a year-on-year decrease of 13.87%, with a net profit attributable to shareholders of 111 million yuan, down 27.60% year-on-year [1]. - The decline in performance is attributed to fluctuations in raw material prices and weak downstream demand, particularly in Q2 2025, where revenue dropped to 1.47 billion yuan, a 21.93% year-on-year decrease [2]. - Despite short-term pressures, the long-term outlook remains positive due to the company's high-end positioning in the nylon chip market and ongoing capacity expansions [2]. Summary by Sections Financial Performance - In H1 2025, the company reported a revenue of 3.03 billion yuan and a net profit of 111 million yuan, with a significant decline in Q2 performance [1]. - The average price of caprolactam in Q2 2025 was 9,193 yuan/ton, down 12.65% from Q1 [2]. - The company expects net profits to grow to 350 million yuan in 2025, 456 million yuan in 2026, and 553 million yuan in 2027, with corresponding PE ratios of 11, 9, and 7 [3][4]. Industry Outlook - The nylon chip industry is projected to reach a capacity of 8.5 million tons by the end of 2025, with a production of 7 million tons and demand of 6.4 million tons [2]. - The company has strategically positioned itself with production bases in multiple locations, enhancing its competitive edge in high-end nylon chips [2]. Investment Recommendations - The company has a strong foundation in nylon 6 polymerization technology and is expanding into nylon 66 products, which is expected to create a second growth curve [3]. - The report forecasts a revenue growth rate of 29.5% in 2025, followed by 26.0% in 2026 and 17.6% in 2027 [4][9].